Tag: precision oncology
-
Oncosyne Advances Pancreatic Cancer Models with Organ-on-a-Chip Technology
Oncosyne is developing a next-generation organ-on-a-chip co-culture module for pancreatic cancer through the INVICTA project, funded by The Research Council of Norway. The project brings together Oncosyne, Professor Elena Rangelova at Sahlgrenska University Hospital, and Professor Stefan Krauss Deiml at the Hybrid Technology Hub (HTH), University of Oslo. The new module is based on HTH’s pump-less,…
-
Oncosyne Expands Pancreatic Cancer Patient Cohort to Strengthen Translational Research
Oncosyne has expanded the clinical study within the INVICTA project to include both chemotherapy-naïve and chemotherapy-treated patients with pancreatic cancer. The expanded study broadens the diversity of patient samples available for research and accelerates the growth of a clinically and molecularly annotated biobank of patient-derived pancreatic cancer tumoroids. Developed in collaboration with Sahlgrenska University Hospital…
-
Oncosyne at ESMO Targeted Anticancer Therapies Congress 2026 in Paris 🇫🇷
Oncosyne presented new research at ESMO TAT 2026 showing how patient-derived tumoroid models can support predictive biomarker discovery and strengthen decision-making in early oncology drug development. In the poster, Spatial pharmacoproteomics analysis of patient-derived tumoroids from colorectal cancer to identify predictive biomarkers, the team demonstrated how combining functional drug testing with high-content spatial analysis generates deeper…
-
Oncosyne is hiring an International Business Development Manager
Oncosyne is hiring, and we are now looking for an International Business Development Manager to join our team. This role will help us bring our functional precision oncology platform to new partners in pharma and biotech. The position includes developing strategies for global outreach, creating sales and presentation material, leading visibility efforts across digital channels,…